Science

Therapeutic science built around engineered cellular niches

Regelife’s science focuses on how biomaterials can shape therapeutic cell behavior, improve delivery, and unlock more durable regenerative effects.

Scientific themes

  • Cell viability and retention
  • Phenotype and function control
  • Tissue-matched delivery environments

Therapeutics

Regenerative Therapies Through Microenvironment Engineering

Neurodegeneration & Neural Circuit Repair

Regelife is initially focused on neurodegenerative diseases, where cell loss, hostile microenvironments, and poor engraftment have limited the promise of cell therapy. We develop biomaterial systems that create a protective, instructive niche for transplanted cells, improving survival, guiding differentiation, and supporting functional neural circuit integration. Our lead programs target amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI), with platform expansion into broader CNS disorders including stroke, Parkinson's disease, and spinal muscular atrophy.

Regenerative Microenvironments

Beyond the central nervous system, many chronic diseases are driven by inflammation, fibrosis, and impaired tissue repair. Regelife's biomaterials are designed to modulate these pathological microenvironments, helping therapeutic cells persist, function, and reshape local tissue responses. We are exploring applications in pulmonary fibrosis and other inflammatory diseases, where precise control of immune signaling, matrix remodeling, and cell behavior is essential for durable outcomes.

Enabling Platform for Next-Generation Cell Therapies

At the core of Regelife is an AI-driven biomaterials design engine that links material properties to cellular behavior. This platform enables the rational design of hydrogels and microenvironments tailored to specific cell types, therapeutic goals, and tissue contexts. By replacing trial and error with predictive design, we aim to accelerate cell therapy development, improve reproducibility, and unlock new therapeutic possibilities across multiple disease areas.